Literature DB >> 27792015

Gender-Specific Degeneration of Dementia-Related Subcortical Structures Throughout the Lifespan.

Viola Luca Nemeth1, Anita Must1, Szatmar Horvath2, Andras Király1, Zsigmond Tamas Kincses1,3, László Vécsei1,4.   

Abstract

Age-related changes in brain structure are a question of interest to a broad field of research. Structural decline has been consistently, but not unambiguously, linked to functional consequences, including cognitive impairment and dementia. One of the areas considered of crucial importance throughout this process is the medial temporal lobe, and primarily the hippocampal region. Gender also has a considerable effect on volume deterioration of subcortical grey matter (GM) structures, such as the hippocampus. The influence of age×gender interaction on disproportionate GM volume changes might be mediated by hormonal effects on the brain. Hippocampal volume loss appears to become accelerated in the postmenopausal period. This decline might have significant influences on neuroplasticity in the CA1 region of the hippocampus highly vulnerable to pathological influences. Additionally, menopause has been associated with critical pathobiochemical changes involved in neurodegeneration. The micro- and macrostructural alterations and consequent functional deterioration of critical hippocampal regions might result in clinical cognitive impairment-especially if there already is a decline in the cognitive reserve capacity. Several lines of potential vulnerability factors appear to interact in the menopausal period eventually leading to cognitive decline, mild cognitive impairment, or Alzheimer's disease. This focused review aims to delineate the influence of unmodifiable risk factors of neurodegenerative processes, i.e., age and gender, on critical subcortical GM structures in the light of brain derived estrogen effects. The menopausal period appears to be of key importance for the risk of cognitive decline representing a time of special vulnerability for molecular, structural, and functional influences and offering only a narrow window for potential protective effects.

Entities:  

Keywords:  Aging; cognitive decline; gender; hippocampus CA1 region; subcortical grey matter

Mesh:

Year:  2017        PMID: 27792015     DOI: 10.3233/JAD-160812

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  6 in total

1.  In multiple facets of subjective memory decline sex moderates memory predictions.

Authors:  Shannon M Drouin; G Peggy McFall; Roger A Dixon
Journal:  Alzheimers Dement (Amst)       Date:  2020-08-25

2.  Female sex is strongly associated with cognitive impairment in HIV infection.

Authors:  Eric Andrius Coelho Duarte; Maria Luiza Benevides; André Luiz Pereira Martins; Edson Pillotto Duarte; Ana Beatriz Santandrea Weller; Laura Oliveira Coutinho de Azevedo; Maria Emília Rodrigues de Oliveira Thaís; Jean Costa Nunes
Journal:  Neurol Sci       Date:  2020-09-14       Impact factor: 3.307

3.  Sirtuin 3 protects against anesthesia/surgery-induced cognitive decline in aged mice by suppressing hippocampal neuroinflammation.

Authors:  Qiang Liu; Yi-Man Sun; Hui Huang; Chen Chen; Jie Wan; Lin-Hui Ma; Yin-Ying Sun; Hui-Hui Miao; Yu-Qing Wu
Journal:  J Neuroinflammation       Date:  2021-02-04       Impact factor: 8.322

4.  Body mass index related to executive function and hippocampal subregion volume in subjective cognitive decline.

Authors:  Ruilin Chen; Guiyan Cai; Shurui Xu; Qianqian Sun; Jia Luo; Yajun Wang; Ming Li; Hui Lin; Jiao Liu
Journal:  Front Aging Neurosci       Date:  2022-08-17       Impact factor: 5.702

Review 5.  Contribution of Inhibitor of Differentiation and Estrogenic Endocrine Disruptors to Neurocognitive Disorders.

Authors:  Andrea Avecilla; Mayur Doke; Jeremy Jovellanos; Vincent Avecilla
Journal:  Med Sci (Basel)       Date:  2018-08-03

6.  Aging and aging-associated diseases: a microRNA-based endocrine regulation hypothesis.

Authors:  Samuil Umansky
Journal:  Aging (Albany NY)       Date:  2018-10-29       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.